Oric Pharmaceuticals, Inc.
ORIC· Nasdaq
Released May 4, 2026, after the close
10-Q filed May 4, 2026, 34 days after period end · 0001193125-26-204047
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$35.77M | -$30.02M | -$25.01M | -$23.95M |
| EPS Diluted | -$0.34 | -$0.42 | -$0.37 | -$0.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR